The FDA is poised to issue a decision soon on KarXT, a potential first-in-class antipsychotic for schizophrenia. What should ...

A CHEAP drug that’s already on the market could be effective against deadly brain tumours, scientists say. Glioblastomas are ...

The two new locally acquired cases are from the same area where the first case was reported last week. In other state news: vaccine hesitancy and the Minnesota measles outbreak; an "epidemic" of ...

When states legalize medical and recreational cannabis, fewer prescriptions for anxiety are filled, but more for depression ...

Data from the federal government shows that Mississippi consistently ranks in the top five in the nation for its rates of ...

A new study in the Journal of Child and Adolescent Psychopharmacology estimates the incidence of neuroleptic malignant ...

But the healthcare system in the US still struggles to provide adequate care for those with serious mental illness ...

About one-third of patients with schizophrenia do not respond to conventional medications, leaving them with one effective ...